Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Crossref DOI link: https://doi.org/10.1007/s13300-021-01010-4
Published Online: 2021-02-17
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lingvay, Ildiko
Kirk, Andreas R.
Lophaven, Søren
Wolden, Michael L.
Shubrook, Jay H.
Funding for this research was provided by:
Novo Nordisk A/S
Text and Data Mining valid from 2021-02-17
Version of Record valid from 2021-02-17
Article History
Received: 18 November 2020
Accepted: 23 January 2021
First Online: 17 February 2021